Report of the Workshop on Differential Pricing & Financing of Essential Drugs
(2001; 20 pages) [French] [Spanish]
Índice de contenido
Ver el documentoExecutive Summary
Cerrar esta carpetaReport of the Workshop
Ver el documento1. Access to essential drugs in developing countries
Ver el documento2. The role of financing in ensuring access to essential drugs
Cerrar esta carpeta3. Differential pricing
Ver el documento3.1 Economic feasibility of differential pricing
Ver el documento3.2 Differential pricing in practice
Ver el documento3.3 Giving effect to differential pricing
Ver el documento3.4 Maintaining separate markets and preventing diversion
Ver el documento3.5 Political feasibility
Ver el documento3.6 Middle-income countries and well-to-do populations in poor countries
Ver el documento4. The role of intellectual property rights
Ver el documento5. Wider use of differential pricing and greater international funding: issues requiring further work
Ver el documentoAnnex 1. Participant List
Ver el documentoAnnex 2. Programme
 

3. Differential pricing

BY DIFFERENTIAL PRICING is meant the adaptation of prices charged by the seller to the purchasing power in different countries. It was widely agreed that differential pricing could and should play an important role in ensuring access to existing essential drugs at affordable prices, especially in poor countries and, in doing so, could help reconcile affordability with incentives for research and development There was considerable agreement that the general objective of differential pricing should be to obtain the best possible prices in poor countries for essential drugs. This was generally seen to be both desirable and feasible.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013